INSP INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Inspire Medical Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Core Viewpoint - Inspire Medical Systems, Inc. is facing a class action lawsuit due to alleged false statements and misleading information regarding the launch of its Inspire V device, which has resulted in significant financial losses for investors [1][4][10]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled "City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, Inc." and covers the period from August 6, 2024, to August 4, 2025 [1]. - Investors have until January 5, 2026, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit alleges that Inspire Medical and its executives violated the Securities Exchange Act of 1934 [1]. Group 2: Allegations Against Inspire Medical - The lawsuit claims that the launch of the Inspire V device was poorly executed, with significant surplus inventory and reluctance from providers to adopt the new treatment [4]. - It is alleged that Inspire Medical failed to complete essential tasks necessary for a successful launch, contrary to their assurances to investors [4]. - On August 4, 2025, Inspire Medical disclosed that the launch faced an "elongated timeframe" due to undisclosed challenges, including incomplete training and onboarding at implanting centers [5]. Group 3: Financial Impact - Following the negative news regarding the Inspire V launch, Inspire Medical reduced its 2025 earnings guidance by over 80% [5]. - The stock price of Inspire Medical declined by more than 32% after the announcement of these issues [5].